your badges 52W Range $5–$9 50% of range Analyst Rating BUY 11 analysts Price Target $16 +126% upside P/E -7.0 ROE -66.8% Net Profit Margin ·

EPRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $7.24
Market Cap $376M
P/E -7.0
EPS $-1.03
Revenue $0
ROE -66.8%
52W Range $5–$9

EPRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$0
2023-12-31 → 2025-12-31
EPS$-1.03
2022-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend EPRX 5Y avg Peer Median Verdict
P/E -7.0 · · ·
P/B 4.6 · 3.7 Overvalued
Price / Cash Flow -13.2 · · ·
Price / Tangible Book 4.6 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -32.1%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 $-0.23 $-0.23 2.0%
March 31, 2026 $-0.23 $-0.23 -0.97%
Dec. 31, 2025 $-0.37 $-0.17 -112.7%
Sept. 30, 2025 $-0.19 $-0.16 -18.4%
June 30, 2025 $-0.26 $-0.19 -38.9%
March 31, 2025 $-0.21 $-0.17 -23.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 202520242023
Revenue $0$0$0
R&D Expense $21M$16M$20M
SG&A Expense $17M$11M$7M
Operating Expenses $38M$27M$28M
Interest Expense $0$603.6K$1M
Interest Income $1M$1M$863.0K
Other Non-op $-152.5K$1M$-1M
Pretax Income $-39M$-26M$-29M
Income Tax $19.1K$1.8K$36.4K
Net Income $-39M$-26M$-28M
EPS (Basic) $-1.03$-0.76$-1.17
EPS (Diluted) $-1.03$-0.76$-1.17
Shares (Basic) 39,956,13333,930,57524,146,623
Shares (Diluted) 39,956,13333,930,57524,146,623
Balance Sheet 18
Metric Trend 202520242023
Cash & Equivalents $81M$33M$19M
Receivables $716.1K$258.1K$153.7K
Prepaid Expense $4M$1M$270.7K
Current Assets $85M$34M$20M
PP&E (Net) $834.4K$357.9K$409.6K
PP&E (Gross) $1M$817.6K$807.7K
Accum. Depreciation $644.2K$459.7K$398.1K
Total Assets $86M$35M$20M
Accounts Payable $942.2K$376.5K$1M
Current Liabilities $6M$3M$19M
Capital Leases $75.9K$0$0
Total Liabilities $6M$3M$19M
Common Stock $195M$116M$93M
Retained Earnings $-170M$-131M$-106M
AOCI $-2M$-4M$-3M
Stockholders' Equity $82M$33M$2M
Liabilities + Equity $86M$35M$20M
Shares Outstanding 51,939,20635,641,60327,282,165
Cash Flow 8
Metric Trend 202520242023
Stock-based Comp $9M$3M$1M
Deferred Tax $0$0$0
Operating Cash Flow $-29M$-30M$-21M
Investing Cash Flow $-588.9K$-75.2K$-73.4K
Net Debt Issued $0$-62.7K$-79.4K
Stock Issued $74M$23M$16M
Net Stock Activity $74M$23M$16M
Financing Cash Flow $76M$46M$21M
Profitability 2
Metric Trend 202520242023
ROA -63.7%-92.4%-143.3%
ROE -66.8%-143.2%-564.3%
Liquidity & Solvency 2
Metric Trend 202520242023
Current Ratio 15.111.11.0
Quick Ratio 14.410.71.0
Efficiency 2
Metric Trend 202520242023
Asset Turnover 0.00.00.0
Receivables Turnover 0.00.0·
Per Share 5
Metric Trend 202520242023
Book Value / Share $1.58$0.94$0.08
Revenue / Share $0.00$0.00$0.00
Cash Flow / Share $-0.71$-0.88$-0.86
Cash / Share $1.55$0.93$0.71
EPS (TTM) $-1.03$-0.76$-1.17
Valuation (TTM) 8
Metric Trend 202520242023
Revenue TTM $0$0$0
Net Income TTM $-39M$-26M$-28M
Market Cap $392M$113M·
P/E -7.3-4.2·
P/B 4.83.4·
P / Tangible Book 4.83.4·
P / Cash Flow -13.7-3.8·
Earnings Yield -13.6%-24.0%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-31
Revenue $0 $0 $0 ·
Net Income $-39M $-26M $-28M $-18M
Diluted EPS $-1.03 $-0.76 $-1.17 $-0.96

Institutional owners (13F) 65 filers · $131.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 65
Value held $131.7M
New positions 18
Exited positions 6
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
18 (-3 vs prior Q) 6 (+3 vs prior Q) 21 (+2 vs prior Q) 16 (+10 vs prior Q) +2.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Affinity Asset Advisors, LLC $10,906,500 1,650,000 8.28% Shares
Balyasny Asset Management L.P. $8,923,599 1,350,015 6.78% Shares
Vivo Capital, LLC $8,923,500 1,350,000 6.77% Shares
SCOTIA CAPITAL INC. $8,782,272 1,343,726 6.67% Shares
PFM Health Sciences, LP $8,002,469 1,210,661 6.08% Shares
GREAT POINT PARTNERS LLC $7,932,000 1,200,000 6.02% Shares
Rubric Capital Management LP $5,733,673 867,424 4.35% Shares
Ikarian Capital, LLC $5,352,388 809,741 4.06% Shares
Woodline Partners LP $4,936,771 746,864 3.75% Shares
Point72 Asset Management, L.P. $4,827,716 730,284 3.67% Shares
AMERIPRISE FINANCIAL INC $4,699,869 711,024 3.57% Shares
Redmile Group, LLC $4,041,354 611,400 3.07% Shares
Seven Fleet Capital Management LP $4,037,289 610,785 3.07% Shares
UBS Group AG $3,431,984 519,211 2.61% Shares
CITADEL ADVISORS LLC $3,318,292 502,011 2.52% Shares
MILLENNIUM MANAGEMENT LLC $2,918,796 441,586 2.22% Shares
Alyeska Investment Group, L.P. $2,478,750 375,000 1.88% Shares
PICTON MAHONEY ASSET MANAGEMENT $2,385,404 360,878 1.81% Shares
Velan Capital Investment Management LP $2,326,720 352,000 1.77% Shares
JANE STREET GROUP, LLC $2,157,990 329,053 1.64% Shares
Aisling Capital Management LP $2,148,250 325,000 1.63% Shares
SummitTX Capital, L.P. $2,107,162 318,784 1.60% Shares
ROYAL BANK OF CANADA $2,058,000 311,435 1.56% Shares
DV EQUITIES, LLC $1,824,360 276,000 1.39% Shares
ORBIMED ADVISORS LLC $1,778,090 269,000 1.35% Shares
BANK OF AMERICA CORP /DE/ $1,749,806 264,721 1.33% Shares
Ally Bridge Group (NY) LLC $1,666,877 252,175 1.27% Shares
CIBC WORLD MARKET INC. $1,539,137 234,673 1.17% Shares
DAFNA Capital Management LLC $1,491,216 225,600 1.13% Shares
TWO SIGMA INVESTMENTS, LP $1,461,365 221,084 1.11% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,405,636 212,653 1.07% Shares
MARSHALL WACE, LLP $1,045,257 158,133 0.79% Shares
TD Waterhouse Canada Inc. $534,915 79,607 0.41% Shares
XTX Topco Ltd $464,452 70,265 0.35% Shares
Annis Gardner Whiting Capital Advisors, LLC $396,600 60,000 0.30% Shares
GOLDMAN SACHS GROUP INC $383,763 58,058 0.29% Shares
RAYMOND JAMES FINANCIAL INC $353,655 53,503 0.27% Shares
1832 Asset Management L.P. $333,356 50,432 0.25% Shares
BNP PARIBAS FINANCIAL MARKETS $305,018 46,145 0.23% Shares
Stonepine Capital Management, LLC $287,476 43,491 0.22% Shares
BANK OF MONTREAL /CAN/ $252,195 38,457 0.19% Shares
GEODE CAPITAL MANAGEMENT, LLC $239,354 36,211 0.18% Shares
Brevan Howard Capital Management LP $229,810 34,767 0.17% Shares
Qube Research & Technologies Ltd $226,307 34,237 0.17% Shares
TORONTO DOMINION BANK $202,769 30,920 0.15% Shares
AXQ CAPITAL, LP $139,802 21,150 0.11% Shares
Jump Financial, LLC $130,878 19,800 0.10% Shares
NATIXIS $115,215 17,644 0.09% Shares
JPMORGAN CHASE & CO $93,486 14,186 0.07% Shares
China Universal Asset Management Co., Ltd. $82,625 12,500 0.06% Shares

Show all 65 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Joseph S. Freedman ×2 filings March 16, 2026 9.00% Amendment · SEC
Joseph S. Freedman (2) Nov. 7, 2024 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

EPRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 11 analysts BUY
Median target $15.75 +117.5%
4 36.4% Strong Buy
6 54.5% Buy
1 9.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

10 analysts · 2026-10-03

Mean target $16.35 +125.8%

← Below all targets Current price $7.24
Low$11.00 Mean$16.35 High$25.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
EPRX $392M -7.3 · · -66.8% ·
XENE $3.59B -10.3 · -4612.1% -56.9% ·
AUPH $2.11B 7.7 20.4% 101.5% 62.7% ·
ABUS $926M -28.3 128.2% -237.9% -42.0% ·
ZYME $1.97B -24.4 38.9% -76.6% -26.9% ·
ACOG $141M -5.5 · -202.2% -43.8% ·
ENGN · · · · · ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 40-F filed Mar 13, 2026